Publication2023
Combination of antimicrobials for non-specific isolated terminal ileal abnormalities - A randomized clinical trial
- Good Health and Well-being
- Empowered Indians
The record
- Type
- Publication
- Date
- 1 October 2023
- Level
- National
- Journal
- Indian Journal of Gastroenterology
- Volume
- 42
- Issue
- 5
- Pages
- 658-667
- Published
- 1 October 2023
- DOI
- 10.1007/s12664-023-01398-w
- Scopus ID
- 85168855512
- ISSN
- 02548860
- Authors
- 10
- Open access
- No
- Citations
- 4
- International co-authorship
- No
- Co-author countries
- IN
Classification
Every label below carries the reasoning it was assigned on, the confidence band it was assigned in, and what produced it. The rubric is published.
UN Sustainable Development Goals
3 Ensure healthy lives and promote well-being for all at all ages
Randomized clinical trial demonstrates that combination antimicrobial therapy (rifaximin, albendazole, tinidazole) and symptomatic treatment both achieve comparable mucosal healing and clinical remission in patients with non-specific terminal ileal abnormalities.
- High confidence
- The subject matter is a strong and direct inference from the record type, the funding or organising body, or the programme context, even where the title alone is thin. Example: an ICMR-funded project against SDG 3, on the strength of the agency.
- Judged
- Judged against the published classification rubric, under the rubric and prompt versions recorded with the run that produced it.
- Produced by
- claude-haiku-4-5-20251001, under kortex-publication-v1
Viksit Bharat @2047
vb-1 Empowered Indians
Derived through the seeded SDG-to-Viksit-Bharat crosswalk from the primary SDG 3 label. Randomized clinical trial demonstrates that combination antimicrobial therapy (rifaximin, albendazole, tinidazole) and symptomatic treatment both achieve comparable mucosal healing and clinical remission in patients with non-specific terminal ileal abnormalities.
- Produced by
- claude-haiku-4-5-20251001, under kortex-publication-v1
Each label above carries the instrument and the version that produced it. How each classification is reached.
Evidence
Kortex hosts no documents. Evidence is an outbound link to the authority that holds it.
No outbound evidence link is recorded for this activity. The record below states which source it came from and when it was last read.
Provenance
Which source system this record came from, how many source rows were resolved into it, and when each was last read.
- Source rows resolved into this record
- 1
Each record carries the date Kortex last read it from its source system. That is a freshness date and not a verification: Kortex records what its sources say and when it read them, and it does not check those statements against any external authority. No claim on this site is described as verified, because none is.
Citing this record
This URL is stable. A record’s permalink is frozen when it is published and is not regenerated if its title is later corrected.
KIIT Deemed to be University. “Combination of antimicrobials for non-specific isolated terminal ileal abnormalities - A randomized clinical trial”. Kortex.